In India, pharmaceutical education is developing rapidly, entering in a new digital era. As the sector embraces automation, ...

WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced the launch of a disruptive technology—quantum ...

By reframing ovarian health as a central driver of longevity rather than just a reproductive milestone, Timeless Biotech aims ...

AI is revolutionizing the IVD market by enhancing diagnostic accuracy and speed. Key opportunities lie in AI integration across workflows, cloud solutions, regulatory support, and supply chain ...

The intricate interplay between microbiomes and their hosts profoundly shapes health, disease, and evolution across diverse ...

Cambridge-based AI Drug turnaround company Ignota Labs has made an audacious bid to revive failed assets from US company ...

Transcription factors are the most powerful genes in our body. They are master regulators and have been implicated in our biggest diseases, even aging itself. Yet, many in the pharmaceutical industry ...

Cancer immunotherapy and chemotherapy are at the forefront of modern cancer treatment, offering significant advancements over traditional methods. Despite ...

Kronos, once valued at $3.5B, Had Two Phase 2 Stage Assets Ignota Labs, the AI drug turnaround company, has announced its acquisition of Kronos's clinical assets, istisociclib, a CDK9 inhibitor, and ...

Rob Wraith looks at whether the rise of AI should prompt us to reconsider our approach to the teaching of coding – and if so, ...

Every biotech software engineer needs a handle on at least one or two languages. Here’s a quick run-down that’s pretty ...